Status:
ACTIVE_NOT_RECRUITING
Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy
Lead Sponsor:
University Hospitals Coventry and Warwickshire NHS Trust
Conditions:
Death, Sudden, Cardiac
Ventricular Arrythmia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A multi-centre observational cohort trial to identify Magnetocardiography (MCG) parameters in the prediction of future ICD therapy. To show a correlation between Arrhythmogenic features on MCG and fut...
Detailed Description
AIM: To explore if VitalScan MCG parameters are able to predict future ICD therapies in patients who meet the requirements for ICD therapy. Magnetocardiography (MCG) Magnetocardiography (MCG) is a no...
Eligibility Criteria
Inclusion
- All patients referred to the cardiology team who meet the following criteria will be invited to participate in the trial:
- Age: 18 years or over
- Can give informed consent
Exclusion
- \- Patients unable to lie still on a bed at a maximum of 30 degree angle for 5 minutes
- Patients with ongoing myocardial infarction or active ischaemia.
- Clinically unstable patients as determined by their treating clinician.
- Patients with existing thoracic metallic implants ie. pacing or defibrillator device, metallic valve will be excluded from the main arm of the trial. The research team will perform a side arm (Device in situ group) trial on 30 participants with either ICDs or pacemakers.
- Age: Under 18 years.
Key Trial Info
Start Date :
August 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2026
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT04352816
Start Date
August 9 2019
End Date
December 31 2026
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Coventry and Warwickshire NHS Trust
Coventry, West Midlands, United Kingdom, CV22DX